Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Outokumpu – Announcement regarding change in holdings

Outokumpu OyjStock exchange releaseAugust 30, 2022 at 2.30 pm EETOutokumpu – Announcement regarding change in holdings Outokumpu Oyj (business identity code: 0215254-2) has on August 29, 2022 received a notification based on Chapter 9, Section 5 of the Finnish Securities Market Act. Société Générale SA’s total holding in the shares and voting rights of Outokumpu has fallen below 5% threshold and was below minimum threshold on August 26, 2022. Their earlier holding in the Outokumpu shares and voting rights was 5.04%. Total direct andindirect holdingsof SociétéGénérale SA

Spinnova’s half-year 2022 reporting and webcast on 8 September 2022

SPINNOVA PLC, PRESS RELEASE, 30 August 2022 at 14:30 p.m. EEST Spinnova’s half-year 2022 reporting and webcast on 8 September 2022 Spinnova Group publishes its half-year report for 1 January to 30 June 2022 on Thursday 8 September 2022 at 8.45 a.m. EEST. The report and presentation material will be available on the company's investor website at spinnovagroup.com after publishing. Spinnova also arranges a half-year webcast event on Thursday 8 September 2022 at 11.00 EEST where Spinnova’s CEO Kim Poulsen and CFO Ben Selby will discuss the company’s January-June events and financial

DexTech Medical AB, Year-end report July 1, 2021 - June 30, 2022

Summary of the fourth quarter (2022-04-01 – 2022-06-30) · Net sales amounted to MSEK 0,0 (0,0) · Operating profit/loss amounted to MSEK -2,1 (-1,5) · Earnings per share* SEK -0.11 (-0.10) * Before and after dilution. Earnings per share: Profit for the period divided by the average number of shares 18,485,857. For the comparison period, the average number of shares was 14,920,478. Amounts in brackets refer to the corresponding period last year. Summary of the financial year (2021-07-01 – 2022-06-30) · Net sales amounted to MSEK 0,0 (0,0) · Operating profit/loss

COSEL adds a 800W to its robust and reliable AEA series of power supplies for demanding industrial and medical applications

•    300% peak power for up to 3,000 milliseconds•    EN62477-1 OVC III certified for safety in industrial applications•    Suitable for medical Body Floating (BF) applications•    Small and compact PCB layout optimized for free-air convection•    High efficiency to reduce energy consumption•    5 year standard warranty COSEL Co, Ltd (6905: Tokyo) today announced the introduction of 800W free-air convection cooling power supplies, the AEA800F series. With demanding applications in mind, the AEA800F is able to deliver 300% peak power for a period of up to 3,000 milliseconds.

Interim Report, January - June 2022

Increased sales and earnings · Quarterly net sales increased by 45 percent and EBITDA before items affecting comparability increased by 51 percent,with a strong contribution from the Norrvidinge acquisition. · Major price increase for fuel and raw materials were partly compensated by contractual customer agreements and successful customer dialogues.   · The acquisition of Börje Holmgrens Åkeri AB, based outside Uppsala, was completed on June 1, 2022. · Bröderna Öhman AB, based in Norrland, was acquired after the end of the quarter. · The acquisition strategy remains firm,

MapsPeople A/S: Share capital increase upon bonus share issuance

MapsPeople A/S | Issuance of bonus sharesCompany Announcement No. 13 - 2022 Aalborg, August 30, 2022 Increase in share capital and number of votes due to bonus share issuance With reference to section 12.1.5 of the Prospectus (available on https://investors.mapspeople.com/), the Board of Directors has introduced an employee share program covering the period June 1[st], 2021 to May 31[st], 2022 for all full-time employees at the Company and its subsidiaries at the time of the IPO in 2021. The employee share program has provided a possibility for the employees to have part of their

MapsPeople A/S: Grant of warrants

MapsPeople A/S | Grant of warrantsCompany Announcement No. 12 - 2022 Aalborg, August 30, 2022 Grant of warrants In order to implement a retention and incentive program, the board of directors of MapsPeople today exercised part of its authorization in section 4.3 of MapsPeople’s articles of association to issue a total of 450,000 warrants. The exercise price is fixed at DKK 5.26 per share corresponding to the opening share price on August 30, 2022. The warrants will vest over 36 months, with 150,000 warrants vesting on August 30, 2023, 100,000 warrants vesting on August 30, 2023,

Trophy Games signs deal acquiring the Lithuanian game development company PIU-PIU LT

Press Release    Copenhagen, 30 August, 2022     Today, Trophy Games Development A/S (Trophy Games), has acquired 80% of the shares in PIU-PIU LT for EUR 300,000. The purchase price is to be paid fully in cash.  PIU-PIU LT is a Lithuanian game developer company who has built an airline tycoon game targeted towards PC. Their current and only title, with the production name SkyHaven , is currently released in early access on Steam. The acquisition will strengthen Trophy Games’ current game portfolio within the

Fellow Bank plans the issuance of a debenture loan of not less than EUR 4 million

FELLOW BANK PLC STOCK EXCHANGE RELEASE, INSIDE INFORMATION 30.8.2022 AT 1:00 PM EESTFellow Bank plans the issuance of a debenture loan of not less than EUR 4 million and assesses options to further strengthen solvency NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SOUTH AFRICA OR SUCH OTHER COUNTRIES OR OTHERWISE IN SUCH CIRCUMSTANCES IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION OF THIS COMMUNICATION WOULD BE UNLAWFUL. Fellow Bank Plc plans to issue a Tier 2

MapsIndoors realizes ARR growth of 93% resulting in a total ARR growth of 61%.

MapsPeople A/S | Financial Report Q2 2022 | Inside InformationCompany Announcement No. 11 - 2022  Aalborg, August 30[th ]2022  Highlights  ● Total Annual Recurring Revenue (ARR) reached DKK 51.5M at the end of Q2 2022 which is 61% higher than DKK  32.0M at the end of Q2 2021.  ● The total growth in ARR is driven by growth from MapsIndoors reaching DKK 39.7M at the end of Q2 2022  which is 93% higher than DKK 20.5M at the end of Q2 2021.  ● MapsPeople increased the MapsIndoors ARR with a total of DKK 10.4M in H1 2022.  ● 96% of MapsIndoors new ARR in Q1 2022 is partner

New US patent approval for Episurf Medical

Episurf Medical (NASDAQ: EPIS B) has received another Notice of Allowance from the United States Patent and Trademark Office (USPTO). The patent, entitled “A method for manufacturing an implant and an implant with two coatings”, is in the area of implant materials and coating characteristics related to Episurf Medical’s devices. “Increased patent protection to support our research and development work is much appreciated, especially in the US market for which we have multiple products in the pipeline” comments Katarina Flodström, COO, Episurf Medical.

Inify Laboratories AB (publ) – Extraordinary General Meeting

Stockholm, Sweden, August 30, 2022; Today, the 30th of August 2022, Inify Laboratories AB, org. no. 559345-4431, held an extraordinary general meeting in Stockholm. Total 31,807,064 shares were represented at the general meeting, which corresponds to 70.3% of the total shares and votes. The meeting decided, with the required majority, on all matters in accordance with the board's previously published proposal. Below follows a summary of the main decisions, for further details please refer to the notice that is available on the company’s website. · Grant Thornton Sweden AB was elected

Stena Scandica now safely at port in Nynäshamn

Just after 11:00 CEST Stena Scandica arrived safely and by her own power at Nynäshamn, Sweden. As a precautionary measure the vessel was escorted by a tugboat and two search and rescue crafts. The passengers have all been well taken care of, and were met by a support team from Stena Line upon arrival. Authorities are at the scene and have started their routine investigation.Yesterday, Monday 29 August, around 12.30 CEST a fire broke out in the cooling container of a truck on car deck onboard Stena Scandica. The vessel was on its way from Nynäshamn, Sweden to Ventspils, Latvia carrying 241

Adelis passes the baton in Nordentic to Corus

Adelis Equity Partners Fund I (“Adelis”) divests its majority stake in Nordentic, the largest dental labs Group in the Nordics, to Corus. Corus is a leading dental labs Group in Europe, with operations in France, Spain, the Netherlands, Belgium and Portugal.Adelis invested in Nordentic in 2017, in partnership with the founders and key management of Nordentic, including the CEO, Johnny Tekin. During Adelis’ ownership, over 20 dental labs have come together as one Group, and as a pioneer in the technical development of the industry. By combining management’s deep industrial knowledge with

Salsa Technology Set to Play Major Role at CGS Brasil 2022

The conference is being held in Florianópolis and it will be the first in-person edition following the pandemic.Salsa Technology is set to play a major role at CGS Brasil 2022 which takes place between 12th - 13th September 2022. The conference is being held in Florianópolis and it will be the first in-person edition following the pandemic.  Salsa will be out in force as a large part of the team is based in the capital of Santa Catarina, which is widely recognised as the ‘Brazilian Silicon Valley’. Salsa Technology 's Lead Account Manager, Camila Alves,

P CAPITAL PARTNERS IV B ISSUES NEW DEBENTURES

PRESS RELEASE Stockholm, 30 August 2022 P Capital Partners IV B AB (publ) today announces that on 13 September 2022, the company will increase its contributed capital by EUR 43.1 million through the issuance of 196,924 series A1 and 18,200 series A2 participation loan debentures at a price of EUR 96 each and 23,205 series B participation loan debentures at a price of EUR 960 each and by an equity contribution of EUR 0.16 million. The new debentures will be eligible for coupon payments from the third quarter 2022. Including the newly issued debentures, P Capital Partners IV B’s

Temporary production stop at Nordic Paper plant in Greåker will have marginal financial impact

The decided production stop at Nordic Paper plant in Greåker in Norway is planned for three days and is estimated to have marginal financial impact on the results of the company in the third quarter. The production stop is due to the currently very high daily prices for electricity in Norway. The plant is part of the segment Natural Greaseproof and corresponds to about half of the production capacity in the segment. For further information, please contact: Henrik Essén, Head of Investor RelationsPhone: +46 730 573801E-mail: henrik.essen@nordic-paper.com

AFRY enters into a global framework agreement with Elkem

Elkem and AFRY have signed a frame agreement to provide engineering and consulting services for Elkem’s production plants globally. The global frame agreement is a continuation of previous local frame agreements.The frame agreement covers engineering and consulting services such as project management, multi-disciplinary engineering, risk assessments, process optimisation, inspections, digitalisation, construction management and delivery of complete electrical, control and automation systems.  Elkem is one of the world's leading companies within environmentally responsible production of

Patent regarding the new generation of treatment systems approved in Europe

SpectraCure's patent application relating to the technical solution in the new generation of treatment systems has been approved by the European Patent Office.The patent describes the technical solution that allows SpectraCure's treatment system to use the same optical fibers (light guide) to deliver the treatment light and to perform the measurements, to enable individual treatment. The solution of using the same optical fibers for measurement as for treatment, makes SpectraCure unique. "SpectraCure's original basic patent, created by Professor Sune Svanberg, describes this solution. In

Trophy Games Appoints Theis Barenkopf Dinesen as COO

. Press Release    Copenhagen, 30 August, 2022   . Trophy Games has added Theis Barenkopf Dinesen to the executive management. Theis is stepping into the COO-role from a 10 month interim position as Organizational Progress and Collaboration Manager at Trophy Games.  Trophy Games Development’s CEO, Søren Gleie, comments: “We hired Theis last year to streamline the organization and work methods, to additionally be the link between a growing and fast moving organization whilst still keeping an agile work approach and strong company culture. During this time Theis has

Orthex Corporation: Managers’ Transactions – (Ståhlberg)

Orthex Corporation, Managers’ transactions, 30 August 2022 at 11.45 a.m. EEST_______________________________________Person subject to the notification requirementName: Salla StåhlbergPosition: Closely associated personPerson discharging managerial responsibilities in issuerName: Tom StåhlbergPosition: Other senior managerIssuer: Orthex CorporationLEI: 7437008RMK8BSWN39T09Notification type: INITIAL NOTIFICATION____________________________________________ Transaction date: 2022-03-10Venue: NASDAQ HELSINKI LTD (XHEL)Instrument type: SHAREISIN: FI4000480504

Repurchase of NCC Series B shares in week 34, 2022

During the period August 22 – August 26, 2022, NCC (LEI-code 213800WRGLW3CY4MHW53) repurchased a total of 220 662 own Series B shares (ISIN: SE0000117970) under the framework of the repurchase program that the Board have decided.The repurchases are part of the repurchase program of a maximum of 10 percent of Series B shares for a total of not more than SEK 1.5 bn that NCC announced on April 27, 2022. The repurchase program extends from May 11, 2022 until the 2023 Annual General Meeting and is being carried out in accordance with the Market Abuse Regulation (EU) No 596/2014 (“MAR”) and the

BioStock: Pila Pharma’s CEO comments on the Q2 report

Malmö-based biotech company Pila Pharma advances towards clinical phase II studies with XEN-D0501 at a steady pace. During the second quarter of 2022 the company announced plans to enter a new indication with the drug candidate. BioStock asked the company’s CEO Dorte X. Gram about her views on the second quarter and about the plans ahead.Read the full article at biostock.se: https://www.biostock.se/en/2022/08/pila-pharmas-ceo-comments-on-the-q2-report/This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

There are no items matching the current filter
There are no more items matching the current filter
Back to top